Thomas Woiwode
QuietNamed in filings at Versant Venture CapitalOn the current fund
- Board seats filed
- 13
Named in filings at Versant Venture CapitalOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Tempest Therapeutics | Biotech & pharma | April 2022 | None on file |
| Santa Ana Bio | Biotech & pharma | May 2021 | None on file |
| Bright Peak Therapeutics | Biotech & pharma | May 2021 | None on file |
| Jengu Therapeutics | Biotech & pharma | September 2020 | None on file |
| Lycia Therapeutics | Biotech & pharma | March 2020 | None on file |
| Aligos Therapeutics | Biotech & pharma | December 2019 | MPM BioVentures, Vivo Innovation |
| Vividion Therapeutics | Biotech & pharma | April 2019 | ARCH Venture Partners, Nextech Viii Carry Scsp |
| Tempest Therapeutics | Biotech & pharma | February 2018 | None on file |
| CRISPR Therapeutics AG | Biotech & pharma | October 2016 | Venbio Select |
| Inception IBD | Biotech & pharma | December 2015 | None on file |
| Kanyos Bio | Biotech & pharma | May 2015 | Vivo Innovation |
| Audentes Therapeutics | Biotech & pharma | November 2014 | 270 Healthcare Growth, Caduceus Capital, Orbimed Asia Partners, Orbimed Genesis |
| Euro Ventures 4 | Not yet classified | December 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Thomas Woiwode on the board, based on 12 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.